Differential control of muscle mass in type 1 and type 2 diabetes mellitus (Q38532367)

3 September 2017

1 reference

title

Differential control of muscle mass in type 1 and type 2 diabetes mellitus (English)

1 reference

3 September 2017

0 references

1 reference

David Sala

1 reference

3 September 2017

Antonio Zorzano

series ordinal

1 reference

3 September 2017

language of work or name

1 reference

20 June 2015

1 reference

Cellular and Molecular Life Sciences

3 September 2017

published in

1 reference

3 September 2017

1 reference

3 September 2017

1 reference

3 September 2017

page(s)

3803-3817

1 reference

Immune mechanisms in type 1 diabetes

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Type 1 diabetes: current concepts in epidemiology, pathophysiology, clinical care, and research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Genetics of Type 1 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Trends in Type 1 diabetes incidence in the UK in 0- to 14-year-olds and in 15- to 34-year-olds, 1991-2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Skeletal muscle insulin resistance is the primary defect in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

The emerging genetic architecture of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Genetics of type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Gene-environment and gene-treatment interactions in type 2 diabetes: progress, pitfalls, and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

NUCKS is a positive transcriptional regulator of insulin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Sedentary behavior: emerging evidence for a new health risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

ON DIABETIC ACIDOSIS: A Detailed Study of Electrolyte Balances Following the Withdrawal and Reestablishment of Insulin Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Effects of type 1 diabetes mellitus on skeletal muscle: clinical observations and physiological mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Protein dynamics in whole body and in splanchnic and leg tissues in type I diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Association between body mass index and muscularity in healthy older Japanese women and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Age variations in the relation of body mass indices to estimates of body fat and muscle mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Excessive loss of skeletal muscle mass in older adults with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Accelerated loss of skeletal muscle strength in older adults with type 2 diabetes: the health, aging, and body composition study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Control of the size of the human muscle mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Signaling in muscle atrophy and hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

What do we really know about the ubiquitin-proteasome pathway in muscle atrophy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

The 26S proteasome: a molecular machine designed for controlled proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Inhibitors of the proteasome reduce the accelerated proteolysis in atrophying rat skeletal muscles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Metabolic acidosis stimulates muscle protein degradation by activating the adenosine triphosphate-dependent pathway involving ubiquitin and proteasomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Autophagy and neurodegeneration: when the cleaning crew goes on strike

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Evidence that lysosomes are not involved in the degradation of myofibrillar proteins in rat skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Autophagic degradation contributes to muscle wasting in cancer cachexia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Mechanisms of muscle wasting in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Chronic kidney disease causes defects in signaling through the insulin receptor substrate/phosphatidylinositol 3-kinase/Akt pathway: implications for muscle atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Muscle wasting in insulinopenic rats results from activation of the ATP-dependent, ubiquitin-proteasome proteolytic pathway by a mechanism including gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Hyperammonemia-mediated autophagy in skeletal muscle contributes to sarcopenia of cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

FoxO3 controls autophagy in skeletal muscle in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Effect of physiologic hyperinsulinemia on skeletal muscle protein synthesis and breakdown in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Insulin sensitivity of protein and glucose metabolism in human forearm skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Effect of insulin with concurrent amino acid infusion on protein metabolism in rapidly growing pubertal children with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Autophagy-regulating TP53INP2 mediates muscle wasting and is repressed in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Insulin and IGF-I stimulate the formation of the eukaryotic initiation factor 4F complex and protein synthesis in C2C12 myotubes independent of availability of external amino acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Insulin and insulin-like growth factor I. Effects on protein synthesis in isolated muscles from lean and goldthioglucose-obese mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Disruption of IRS-2 causes type 2 diabetes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Insulin receptor substrates Irs1 and Irs2 coordinate skeletal muscle growth and metabolism via the Akt and AMPK pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Upstream and downstream of mTOR

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Akt2 mRNA is highly expressed in embryonic brown fat and the AKT2 kinase is activated by insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Akt1/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Inducible activation of Akt increases skeletal muscle mass and force without satellite cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Akt regulates growth by directly phosphorylating Tsc2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Atrophy of S6K1(-/-) skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

The role of the Atg1/ULK1 complex in autophagy regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Sustained activation of mTORC1 in skeletal muscle inhibits constitutive and starvation-induced autophagy and causes a severe, late-onset myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Autophagy is required to maintain muscle mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Glycogen synthase kinase-3 is the predominant insulin-regulated eukaryotic initiation factor 2B kinase in skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated Type I (slow twitch/red muscle) fiber genes, and impaired glycemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Ubiquitin conjugation by the N-end rule pathway and mRNAs for its components increase in muscles of diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

PTEN expression contributes to the regulation of muscle protein degradation in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

IGF-1 and IGF-binding proteins and bone mass, geometry, and strength: relation to metabolic control in adolescent girls with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Insulin-like growth factor-1 and its binding proteins, IGFBP-1 and IGFBP-3, in adolescents with type-1 diabetes mellitus and microalbuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Distinct growth hormone receptor signaling modes regulate skeletal muscle development and insulin sensitivity in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Resting and exercise-induced IL-6 levels in children with Type 1 diabetes reflect hyperglycemic profiles during the previous 3 days

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Altered kinetics of interleukin-6 and other inflammatory mediators during exercise in children with type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Acute hyperglycaemia induces an inflammatory response in young patients with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Stat3 activation links a C/EBPδ to myostatin pathway to stimulate loss of muscle mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Evidence for the involvement of interleukin 6 in experimental cancer cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Signaling mechanisms through gp130: a model of the cytokine system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Cytokine signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Mechanisms stimulating muscle wasting in chronic kidney disease: the roles of the ubiquitin-proteasome system and myostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular co-morbidity: an analysis of the PROactive study population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Increased muscle protein breakdown in chronic hemodialysis patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Insulin resistance accelerates muscle protein degradation: Activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Muscle atrophy, inflammation and clinical outcome in incident and prevalent dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Role of muscle mass and muscle quality in the association between diabetes and gait speed

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: the Korean Sarcopenic Obesity Study (KSOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Difficulties with physical function associated with obesity, sarcopenia, and sarcopenic-obesity in community-dwelling elderly women: the EPIDOS (EPIDemiologie de l'OSteoporose) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Sarcopenic obesity: molecular clues to a better understanding of its pathogenesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Insulin in methionine and homocysteine kinetics in healthy humans: plasma vs. intracellular models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Synthesis rate of muscle proteins, muscle functions, and amino acid kinetics in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Insulin resistance of protein metabolism in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Insulin resistance of amino acid and protein metabolism in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Muscle protein anabolism in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Proteomics analysis of human skeletal muscle reveals novel abnormalities in obesity and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Positional cloning of the mouse obese gene and its human homologue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

The physiology of obese-hyperglycemic mice [ob/ob mice].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Obese and diabetes: Two mutant genes causing diabetes-obesity syndromes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Leptin receptor missense mutation in the fatty Zucker rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Lilly Lecture 1994. The beta-cell in diabetes: from molecular genetics to clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonist, JTT-501, on diabetic complications in Zucker diabetic fatty rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Diet-induced type II diabetes in C57BL/6J mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Islet gene expression and function in type 2 diabetes; studies in the Goto-Kakizaki rat and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

beta-cell function and viability in the spontaneously diabetic GK rat: information from the GK/Par colony

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Leptin administration favors muscle mass accretion by decreasing FoxO3a and increasing PGC-1alpha in ob/ob mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Antidiabetic properties of zinc-alpha2-glycoprotein in ob/ob mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Increasing muscle mass improves vascular function in obese (db/db) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Absence of functional leptin receptor isoforms in the POUND (Lepr(db/lb)) mouse is associated with muscle atrophy and altered myoblast proliferation and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Effect of a low-protein diet supplemented with ketoacids on skeletal muscle atrophy and autophagy in rats with type 2 diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Chronic high fat feeding attenuates load-induced hypertrophy in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

DOR/Tp53inp2 and Tp53inp1 constitute a metazoan gene family encoding dual regulators of autophagy and transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

TP53INP1s and homeodomain-interacting protein kinase-2 (HIPK2) are partners in regulating p53 activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Identification of a novel modulator of thyroid hormone receptor-mediated action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

DOR undergoes nucleo-cytoplasmic shuttling, which involves passage through the nucleolus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

The nuclear cofactor DOR regulates autophagy in mammalian and Drosophila cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

The TP53INP2 protein is required for autophagy in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Deacetylation of nuclear LC3 drives autophagy initiation under starvation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Sarcopenic Obesity Predicts Instrumental Activities of Daily Living Disability in the Elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Proteasome inhibition in skeletal muscle cells unmasks metabolic derangements in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1954-7

Cloning, chromosomal localization and expression analysis of the mouse Akt2 oncogene.

21 January 2018

1 reference

12 December 2020

Functional and histological characteristics of skeletal muscle and the effects of leptin in the genetically obese (ob/ob) mouse

1 reference

12 December 2020

Increased energy expenditure in poorly controlled Type 1 (insulin-dependent) diabetic patients

1 reference

12 December 2020

Serum IL-1beta, IL-2, and IL-6 in insulin-dependent diabetic children

1 reference

12 December 2020

Effect of streptozotocin diabetes and insulin treatment on the rate of protein synthesis in tissues of the rat in vivo

1 reference

12 December 2020

A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells

1 reference

12 December 2020

Obesity in the new millennium

1 reference

12 December 2020

Role of apoptosis in failure of beta-cell mass compensation for insulin resistance and beta-cell defects in the male Zucker diabetic fatty rat

1 reference

12 December 2020

Role of insulin-like growth factors in embryonic and postnatal growth

1 reference

12 December 2020

Definition, classification and diagnosis of diabetes, prediabetes and metabolic syndrome

1 reference

12 December 2020

TP53INP1 is a novel p73 target gene that induces cell cycle arrest and cell death by modulating p73 transcriptional activity

1 reference

12 December 2020

Diffuse muscle fiber atrophy in newly diagnosed diabetes

1 reference

12 December 2020

Diabetes, a New Mutation in the Mouse

1 reference

12 December 2020

Role of hyperglucagonemia in catabolism associated with type 1 diabetes: effects on leucine metabolism and the resting metabolic rate

1 reference

12 December 2020

Hyperaminoacidaemia at postprandial levels does not modulate glucose metabolism in type 2 diabetes mellitus

1 reference

12 December 2020

Acidosis and glucocorticoids concomitantly increase ubiquitin and proteasome subunit mRNAs in rat muscle

1 reference

12 December 2020

Skeletal muscle mass and distribution in 468 men and women aged 18-88 yr

1 reference

12 December 2020

Pathophysiology of insulin resistance in human disease.

1 reference

12 December 2020

Hyperglucagonemia increases resting metabolic rate in man during insulin deficiency

1 reference

12 December 2020

Recent advances in the molecular genetics of type 2 diabetes mellitus

1 reference

12 December 2020

Production of spontaneous diabetic rats by repetition of selective breeding

1 reference

12 December 2020

Skeletal muscle protein anabolic response to increased energy and insulin is preserved in poorly controlled type 2 diabetes

1 reference

12 December 2020

Evaluation of signals activating ubiquitin-proteasome proteolysis in a model of muscle wasting

1 reference

12 December 2020

Diagnosis and classification of diabetes mellitus

1 reference

12 December 2020

Influence of insulin on leucine kinetics in the whole body and across the forearm in post-absorptive insulin dependent diabetic (type 1) patients

1 reference

12 December 2020

Insulin stimulation of protein synthesis in cultured skeletal and cardiac muscle cells

1 reference

12 December 2020

Diabetes and the hypothalamo-pituitary-adrenal (HPA) axis

1 reference

12 December 2020

Increased Islet Volume but Unchanged Islet Number in ob/ob Mice

1 reference

12 December 2020

Activation of the ATP-ubiquitin-proteasome pathway in skeletal muscle of cachectic rats bearing a hepatoma

1 reference

12 December 2020

Muscle protein breakdown and the critical role of the ubiquitin-proteasome pathway in normal and disease states

1 reference

12 December 2020

Glucocorticoids activate the ATP-ubiquitin-dependent proteolytic system in skeletal muscle during fasting

1 reference

12 December 2020

Functional abnormalities of islets of Langerhans of obese hyperglycemic mouse

1 reference

12 December 2020

Non-steroidal anti-inflammatory drugs for preventing heterotopic bone formation after hip arthroplasty

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD001160.PUB2

Identifiers

DOI

10.1007/S00018-015-1954-7

1 reference

3 September 2017

1 reference